# Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery

> **NCT00814580** · PHASE3 · COMPLETED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 382 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Tapentadol IR
- **DRUG:** Oxycodone IR

## Key facts

- **NCT ID:** NCT00814580
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2012-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814580, "Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00814580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*